During the past decade, Ospedale Nuovo Della Versilia; Divisione Di Oncologia Medica conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 11 clinical trials were completed, i.e. on average, 61.1% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 6 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ospedale Nuovo Della Versilia; Divisione Di Oncologia Medica" #1 sponsor was "Hoffmann-La Roche" with 7 trials, followed by "Boehringer Ingelheim" with 2 trials sponsored, "Consorzio Oncotech" with 2 trials sponsored, "Fadoi Foundation, Italy" with 2 trials sponsored and "Fondazione Ricerca Traslazionale" with 2 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale Nuovo Della Versilia; Divisione Di Oncologia Medica" #1 collaborator was "Clinical Research Technology S.r.l." with 3 trials as a collaborator, "Biorobotic Institute Scuola Superiore sant'Anna Pisa" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Mario Negri Institute for Pharmacological Research" with 1 trials as a collaborator and "Medical Research Council Population Health Research Unit, CTSU, University of Oxford (academic lead)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale Nuovo Della Versilia; Divisione Di Oncologia Medica" are "Metastatic Breast Cancer" (3 trials), "Breast Cancer" (2 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials), "Non Small Cell Lung Cancer" (2 trials) and "Non-Small Cell Lung Cancer" (2 trials). Many other conditions were trialed in "Ospedale Nuovo Della Versilia; Divisione Di Oncologia Medica" in a lesser frequency.

Most popular intervention types in "Ospedale Nuovo Della Versilia; Divisione Di Oncologia Medica" are "Drug" (18 trials), "Device" (5 trials), "Other" (5 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Paclitaxel" (4 trials), "Placebo" (3 trials), "Bevacizumab" (2 trials), "Carboplatin" (2 trials) and "Docetaxel" (2 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale Nuovo Della Versilia; Divisione Di Oncologia Medica" are 26 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Ospedale Nuovo Della Versilia; Divisione Di Oncologia Medica". undefined are not yet recruiting, 5 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Ospedale Nuovo Della Versilia; Divisione Di Oncologia Medica, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale Nuovo Della Versilia; Divisione Di Oncologia Medica, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".